Automatsko proširenje i primjena računalnog grozda korištenjem dual-boot principa

The paper presents an innovative and simple way of creating computer clustering and obtaining HPC clusters using computers in the classroom, Ethernet facilities and open source software. Automatic enlarge of a computer cluster is a cost-effective way to increase available computing power. This is achieved by forming a computer cluster from the computers in the classroom. The main aim of this paper is to present a solution that will use existing resources in the computer classroom, for applying complex computer services/jobs under the Linux operating system. The execution of these services/jobs programs is performed at the time when the computing resources are not in used in learning under the Windows operating system. A real-life example of applying computers in dual-boot Windows/Linux work mode along with the developed software application support is presented in a teaching environment. The implementation also includes logistics and support for automatic computer clustering and for service/job programs execution. The primary goal is to use existing resources for useful applications in education in the image programming, simulations and volume rendering.U radu je prikazan inovativan i jednostavan način stvaranja računalnih klastera i dobivanja HPC klastera korištenjem postojećih računala u učionici, Ethernet objekata, i open source softvera. Automatsko oblikovanje računalnog klastera je ekonomičan način da se poveća raspoloživa računalna snaga. To se postiže formiranjem računalnog klastera od postojećih računala u učionici. Glavni cilj ovog rada je prikazati rješenje koja će koristiti postojeće resurse u okruženju računalne učionice za izvođenje složenih računalnih poslova koji zahtjevaju vec´u računalnu snagu pod Linux operativnim sustavom. Izvršenje tih poslova se obavlja u vrijeme kada se računalni resursi ne koriste za obrazovanje pod Windows operativnim sustavom. Prikazan je primjer primjene računala u dual-boot Windows/Linux modu rada uz razvijene originalne programske podrške za aplikacije u obrazovnom okruženju. Provedba također uključuje logistiku i podršku za automatsko klasteriranje računala i izvršavanje poslova. Primarni cilj je iskorištavanje postojećih resursa za korisne aplikacije u obrazovanju primarno u području programiranja slike, simulacije i renderiranja. Rezultati provedenog principa su prikazani

The effect of bioturbation in pelagic sediments: Lessons from radioactive tracers and planktonic foraminifera in the Gulf of Aqaba, Red Sea

Studies of recent environmental perturbations often rely on data derived from marine sedimentary records. These records are known to imperfectly inscribe the true sequence of events, yet there is large uncertainty regarding the corrections that should be employed to accurately describe the sedimentary history. Here we show in recent records from the Gulf of Aqaba, Red Sea, how events of the abrupt disappearance of the planktonic foraminifer Globigerinoides sacculifer, and episodic deposition of the artificial radionuclide137Cs, are significantly altered in the sedimentary record compared to their known past timing. Instead of the abrupt disappearance of the foraminifera, we observe a prolonged decline beginning at core depth equivalent to ∼30 y prior to its actual disappearance and continuing for decades past the event. We further observe asymmetric smoothing of the radionuclide peak. Utilization of advection–diffusion–reaction models to reconstruct the original fluxes based on the known absolute timing of the events reveal that it is imperative to use a continuous function to describe bioturbation. Discretization of bioturbation into mixed and unmixed layers significantly shifts the location of the modeled event. When bioturbation is described as a continuously decreasing function of depth, the peak of a very short term event smears asymmetrically but remains in the right depth. When sudden events repeat while the first spike is still mixed with the upper sediment layer, bioturbation unifies adjacent peaks. The united peak appears at an intermediate depth that does not necessarily correlate with the timing of the individual events. In a third case, a long lasting sedimentary event affected by bioturbation, the resulting peak is rather weak compared to the actual event and appears deeper in the sediment column than expected based on the termination of the event. The model clearly shows that abrupt changes can only endure in the record if a thick sediment layer settled on the sediment–water interface at once or if bioturbation rates decreased to very low values for a prolonged period of time. In any other case smearing by bioturbation makes an abrupt event appear to have started shortly before the real timing and end long after its true termination

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

Purpose To evaluate risk factors for GI adverse events (AEs) within a phase III trial of bevacizumab in first-line ovarian cancer therapy. Patients and Methods Women with previously untreated advanced disease after surgery were randomly allocated to six cycles of platinum-taxane chemotherapy plus placebo cycles (C)2 to C22 (R1); chemotherapy plus bevacizumab C2 to C6 plus placebo C7 to C22 (R2); or chemotherapy plus bevacizumab C2 to C22 (R3). Patients were evaluated for history or on-study development of potential risk factors for GI AEs defined as grade 2 perforation, fistula, necrosis, or hemorrhage. Results Of 1,873 patients enrolled, 1,759 (94%) were evaluable, and 2.8% (50 of 1,759) experienced a GI AE: 10 of 587 (1.7%, R1), 20 of 587 (3.4%, R2), and 20 of 585 (3.4%, R3). Univariable analyses indicated that previous treatment of inflammatory bowel disease (IBD; P = .005) and small bowel resection (SBR; P = .032) or large bowel resection (LBR; P = .012) at primary surgery were significantly associated with a GI AE. The multivariable estimated relative odds of a GI AE were 13.4 (95% CI, 3.44 to 52.3; P \u3c .001) for IBD; 2.05 (95% CI, 1.09 to 3.88; P = .026) for LBR; 1.95 (95% CI, 0.894 to 4.25; P = .093) for SBR; and 2.15 for bevacizumab exposure (aggregated 95% CI, 1.05 to 4.40; P = .036). Conclusion History of treatment for IBD, and bowel resection at primary surgery, increase the odds of GI AEs in patients receiving first-line platinum-taxane chemotherapy for advanced ovarian cancer. After accounting for these risk factors, concurrent bevacizumab doubles the odds of a GI AE, but is not appreciably increased by continuation beyond chemotherapy

Participatory action research in two communities in Bolivia and the United States

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/66665/2/10.1177_002087289203500214.pd

Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit

<p>Abstract</p> <p>background</p> <p>The pace of novel medical treatments and approaches to therapy has accelerated in recent years. Unfortunately, many potential therapeutic advances do not fulfil their promise when subjected to randomized controlled trials. It is therefore highly desirable to speed up the process of evaluating new treatment options, particularly in phase II and phase III trials. To help realize such an aim, in 2003, Royston and colleagues proposed a class of multi-arm, two-stage trial designs intended to eliminate poorly performing contenders at a first stage (point in time). Only treatments showing a predefined degree of advantage against a control treatment were allowed through to a second stage. Arms that survived the first-stage comparison on an intermediate outcome measure entered a second stage of patient accrual, culminating in comparisons against control on the definitive outcome measure. The intermediate outcome is typically on the causal pathway to the definitive outcome (i.e. the features that cause an intermediate event also tend to cause a definitive event), an example in cancer being progression-free and overall survival. Although the 2003 paper alluded to multi-arm trials, most of the essential design features concerned only two-arm trials. Here, we extend the two-arm designs to allow an arbitrary number of stages, thereby increasing flexibility by building in several 'looks' at the accumulating data. Such trials can terminate at any of the intermediate stages or the final stage.</p> <p>Methods</p> <p>We describe the trial design and the mathematics required to obtain the timing of the 'looks' and the overall significance level and power of the design. We support our results by extensive simulation studies. As an example, we discuss the design of the STAMPEDE trial in prostate cancer.</p> <p>Results</p> <p>The mathematical results on significance level and power are confirmed by the computer simulations. Our approach compares favourably with methodology based on beta spending functions and on monitoring only a primary outcome measure for lack of benefit of the new treatment.</p> <p>Conclusions</p> <p>The new designs are practical and are supported by theory. They hold considerable promise for speeding up the evaluation of new treatments in phase II and III trials.</p

The power of practice: simulation training improving the quality of neonatal resuscitation skills in Bihar, India.

BACKGROUND: Globally, neonatal mortality accounts for nearly half of under-five mortality, and intrapartum related events are a leading cause. Despite the rise in neonatal resuscitation (NR) training programs in low- and middle-income countries, their impact on the quality of NR skills amongst providers with limited formal medical education, particularly those working in rural primary health centers (PHCs), remains incompletely understood. METHODS: This study evaluates the impact of PRONTO International simulation training on the quality of NR skills in simulated resuscitations and live deliveries in rural PHCs throughout Bihar, India. Further, it explores barriers to performance of key NR skills. PRONTO training was conducted within CARE India's AMANAT intervention, a maternal and child health quality improvement project. Performance in simulations was evaluated using video-recorded assessment simulations at weeks 4 and 8 of training. Performance in live deliveries was evaluated in real time using a mobile-phone application. Barriers were explored through semi-structured interviews with simulation facilitators. RESULTS: In total, 1342 nurses participated in PRONTO training and 226 NR assessment simulations were matched by PHC and evaluated. From week 4 to 8 of training, proper neck extension, positive pressure ventilation (PPV) with chest rise, and assessment of heart rate increased by 14%, 19%, and 12% respectively (all p ≤ 0.01). No difference was noted in stimulation, suction, proper PPV rate, or time to completion of key steps. In 252 live deliveries, identification of non-vigorous neonates, use of suction, and use of PPV increased by 21%, 25%, and 23% respectively (all p < 0.01) between weeks 1-3 and 4-8. Eighteen interviews revealed individual, logistical, and cultural barriers to key NR skills. CONCLUSION: PRONTO simulation training had a positive impact on the quality of key skills in simulated and live resuscitations throughout Bihar. Nevertheless, there is need for ongoing improvement that will likely require both further clinical training and addressing barriers that go beyond the scope of such training. In settings where clinical outcome data is unreliable, data triangulation, the process of synthesizing multiple data sources to generate a better-informed evaluation, offers a powerful tool for guiding this process

Dose distribution in the thyroid gland following radiation therapy of breast cancer-a retrospective study

<p>Abstract</p> <p>Purpose</p> <p>To relate the development of post-treatment hypothyroidism with the dose distribution within the thyroid gland in breast cancer (BC) patients treated with loco-regional radiotherapy (RT).</p> <p>Methods and materials</p> <p>In two groups of BC patients postoperatively irradiated by computer tomography (CT)-based RT, the individual dose distributions in the thyroid gland were compared with each other; Cases developed post-treatment hypothyroidism after multimodal treatment including 4-field RT technique. Matched patients in Controls remained free for hypothyroidism. Based on each patient's dose volume histogram (DVH) the volume percentages of the thyroid absorbing respectively 20, 30, 40 and 50 Gy were then estimated (V20, V30, V40 and V50) together with the individual mean thyroid dose over the whole gland (MeanTotGy). The mean and median thyroid dose for the included patients was about 30 Gy, subsequently the total volume of the thyroid gland (VolTotGy) and the absolute volumes (cm³) receiving respectively < 30 Gy and ≥ 30 Gy were calculated (Vol < 30 and Vol ≥ 30) and analyzed.</p> <p>Results</p> <p>No statistically significant inter-group differences were found between V20, V30, V40 and V50Gy or the median of MeanTotGy. The median VolTotGy in Controls was 2.3 times above VolTotGy in Cases (ρ = 0.003), with large inter-individual variations in both groups. The volume of the thyroid gland receiving < 30 Gy in Controls was almost 2.5 times greater than the comparable figure in Cases.</p> <p>Conclusions</p> <p>We concluded that in patients with small thyroid glands after loco-radiotherapy of BC, the risk of post-treatment hypothyroidism depends on the volume of the thyroid gland.</p

ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival

BACKGROUND: The clinico-pathological and molecular heterogeneity of epithelial ovarian cancer (EOC) complicates its early diagnosis and successful treatment. Highly aneuploid tumours and the presence of ascitic fluids are hallmarks of EOC. Two microcephalyassociated proteins, abnormal spindle-like microcephaly-associated protein (ASPM) and microcephalin, are involved in mitosis and DNA damage repair. Their expression is deregulated at the RNA level in EOC. Here, ASPM and microcephalin protein expression in primary cultures established from the ascites of patients with EOC was determined and correlated with clinical data to assess their suitability as biomarkers. METHODS: Five established ovarian cancer cell lines, cells derived from two benign ovarian ascites samples and 40 primary cultures of EOC derived from ovarian ascites samples were analysed by protein slot blotting and/or immunofluorescence to determine ASPM and microcephalin protein levels and their cellular localisation. Results were correlated with clinico-pathological data. RESULTS: A statistically significant correlation was identified for ASPM localisation and tumour grade, with high levels of cytoplasmic ASPM correlating with grade 1 tumours. Conversely, cytoplasmic microcephalin was only identified in high-grade tumours. Furthermore, low levels of nuclear microcephalin correlated with reduced patient survival. CONCLUSION: Our results suggest that ASPM and microcephalin have the potential to be biomarkers in ovarian cance